Skip to main content
. 2019 Nov;16(4):811–821. doi: 10.20892/j.issn.2095-3941.2019.0209

5.

5

Four subgroups of LADC cases based on routinely used molecular biomarker investigations. The graphic pie chart shows the frequency of LADC patients for the potential pairing of systemic therapies.